Athira Pharma
$20.209876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$20.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
$0.00 (0.00%) As of 2:35 PM UTC today
Why Robinhood?
You can buy or sell Athira Pharma and other stocks, options, and ETFs commission-free!
About ATHA
Athira Pharma, Inc. Common Stock, also called Athira Pharma, is a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company was founded by Leen Kawas and Joseph Harding in 2011 and is headquartered in Seattle, WA. The listed name for ATHA is Athira Pharma, Inc. Common Stock.
CEO
Leen Kawas
Employees
15
Headquarters
Bothell, Washington
Founded
2011
Market Cap
787.70M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
569.90K
High Today
$20.36
Low Today
$20.10
Open Price
$20.26
Volume
15.65K
52 Week High
$34.79
52 Week Low
$15.79
Collections
ATHA Earnings
-$1.12
-$0.75
-$0.37
$0.00
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 15, After Hours